Sunday, 22 November 2026|Independent Journalism • National Perspective
SearchE-MagazineLogin
Nation Path India
Nation PathInsight • Truth • Global View
Breaking
Latest news updates from NationPath India•Latest news updates from NationPath India•
HomeNationalInternationalPoliticsEconomyDefenceTechnologySports
Sections

NationPath India

Premium Indian digital newsroom delivering credible journalism, national perspectives, and stories that matter.

Categories

  • National
  • International
  • Politics
  • Economy
  • Defence

Newsletter

Get important updates directly from NationPath India.

Follow

© 2026 NationPath India. All rights reserved. Crafted by : TitanArt Studio, India

AboutContactAdvertisePrivacyTermsEditorial Policy
Home/Health/Government Restricts Chlorpheniramine-Phenylephrine Combinations for Children Below Four
Advertisement
Health

Government Restricts Chlorpheniramine-Phenylephrine Combinations for Children Below Four

Nation Path News Desk|22 August 2026|2 min read|353 views
Medicine packaging representing the government warning against specified Chlorpheniramine-Phenylephrine combinations for children below four years.
Visual Report
Government mandates warning on specified Chlorpheniramine-Phenylephrine combinations for children below four years.
NationPath Visual Report
Share
NationPath India

NationPath Brief

Essential context before you continue reading

30 sec overview
“

The government has restricted the manufacturing, sale and distribution of fixed-dose combinations (FDCs) containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children below four years of age. Manufacturers have been directed to prominently display a warning that these combinations must not be used for children under four.

Editorial Brief• Quick summary curated for readers

NationPath Intelligence

The Story Behind The News

Context, analysis and verified insights that explain the story beyond the headline.

Background

Context and information behind the story

Fixed-dose combinations contain two or more active pharmaceutical ingredients in a single formulation. Government authorities periodically review such combinations to assess their safety, effectiveness and appropriate use. The latest restriction specifically concerns combinations containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children below four years of age

Key Takeaways

Important points readers should remember

FDCs containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride are restricted for children below four.

A mandatory warning must be displayed clearly on affected products.

The warning applies to labels, package inserts and promotional material. The government cited potential risks and the availability of safer alternatives.

The decision follows recommendations from drug regulatory bodies.

The government has imposed restrictions on the manufacturing, sale and distribution of all fixed-dose combinations containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for use in children below four years of age.

The Ministry of Health and Family Welfare has directed manufacturers to prominently display a clear warning on products containing these combinations.

Editorial Insight

Key Highlights

Important points readers should notice.

Restrictions apply to specified FDCs containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride.

The restriction concerns children below four years of age.

Manufacturers must display a mandatory warning. The warning must appear on the label and package insert.

Promotional literature must also carry the warning. The government cited safety concerns and availability of safer alternatives.

The move follows broader scrutiny of fixed-dose combination medicines.

The mandatory warning states:

“Fixed Dose Combination shall not be used in children below four years of age.”

The warning is required to appear on the label, package insert and promotional literature associated with the formulations.

Editorial Analysis

Why This Matters

The notification directly concerns medicines intended for young children and requires manufacturers to clearly communicate the age restriction. The measure is intended to ensure that parents, caregivers and healthcare professionals are made aware that these specified combinations should not be used in children below four years.

According to the government notification, the restriction has been introduced because the use of such combinations may pose risks to children below four years of age, while safer alternatives are available.

The move is part of the government's broader regulatory approach towards the safety and appropriate use of medicines.

The latest notification specifically requires manufacturers to ensure that the age-related warning is clearly communicated wherever the affected formulations are marketed or supplied.

The government had also taken wider action on fixed-dose combination medicines earlier this year.

In June, the Ministry of Health and Family Welfare prohibited the manufacturing, sale and distribution of 16 fixed-dose combination drugs for human use across the country.

That decision followed recommendations from an Expert Committee and the Drug Technical Advisory Board.

Future Outlook

What's Next

Manufacturers will have to comply with the government's labelling and warning requirements for the affected formulations. Regulatory authorities will continue monitoring the manufacture, sale and distribution of medicines covered by the notification.

FAQ

Frequently Asked Questions

Clear answers to help readers understand the story better.

The restriction covers fixed-dose combinations containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children below four years.
Advertisement

Next Story

Medical graduates attend the 12th convocation ceremony of ABVIMS and Dr. Ram Manohar Lohia Hospital in New Delhi.
Health
Continue Reading20 Nov 2026
Health

President Murmu Urges New Doctors to Prioritise Ethics and Compassion as 324 Medical Graduates Receive Degrees

President Droupadi Murmu on November 20, 2026, addressed the 12th convocation ceremony of the Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital in New Delhi, urging newly qualified doctors...

20 Nov 2026
Read Full Story

NationPath Astro Intelligence

Wellness Intelligence

Discover lifestyle patterns and personalised wellness insights.

Explore

Related Stories

More stories you may want to explore

6 Stories
Medical graduates attend the 12th convocation ceremony of ABVIMS and Dr. Ram Manohar Lohia Hospital in New Delhi.
Health

Health

President Murmu Urges New Doctors to Prioritise Ethics and Compassion as 324 Medical Graduates Receive Degrees

President Droupadi Murmu on November 20, 2026, addressed the 12th convocation ceremony of the Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital in New Delhi, urging newly qualified doctors...

20 Nov 2026

Read →
Visitors exploring the Union Health Ministry's public-health awareness pavilion at an Indian trade fair.
Health

Health

Health Ministry's IITF 2026 Pavilion Records Over 12,189 Visits in Five Days, Focuses on Preventive Healthcare

The Union Ministry of Health and Family Welfare's Health Pavilion at the India International Trade Fair (IITF) 2026 has recorded more than 12,189 stall visits during its first five days, highlighting public interest in health...

20 Nov 2026

Read →
Indian healthcare professionals participate in a public-health awareness programme focused on responsible medical technology and protection of the girl child.
Health

Health

Purana Qila in Delhi, where the ASTITVA exhibition will showcase archaeological evidence and India's literary heritage during the SCO Civilisational Dialogue Forum.

The Union Government has reviewed the implementation of the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, with a renewed focus on preventing gender-biased sex selection and ensuring the responsible use of...

19 Nov 2026

Read →
Pharmaceutical warehouse professional inspecting medicine packages and storage conditions in a modern distribution facility.
Health

Health

India Proposes Stricter Drug Storage and Distribution Rules to Protect Medicine Quality

The Union Ministry of Health and Family Welfare has proposed incorporating Good Storage and Distribution Practices (GSDP) guidelines for pharmaceutical products into the Drugs Rules, 1945, in a move aimed at strengthening quality control across...

19 Nov 2026

Read →
Indian adults participating in a yoga and wellness awareness activity representing the 9th Naturopathy Day and preventive healthcare campaign.
Health

Health

India to Observe 9th Naturopathy Day on November 18; Focus on Obesity Prevention and Healthy Living

India will observe the 9th Naturopathy Day on November 18, 2026, with a nationwide focus on preventive healthcare, healthy lifestyles and the management of lifestyle-related disorders, according to an announcement by the Ministry of Ayush...

17 Nov 2026

Read →
Doctor consulting a patient at a modern public healthcare facility in India.
Health

Health

Government Health Spending Crosses ₹4.14 Lakh Crore as Out-of-Pocket Healthcare Costs Fall to 42.7%: National Health Accounts

India's government health expenditure reached ₹4.14 lakh crore in 2023–24, more than three times the ₹1.30 lakh crore recorded in 2013–14, while the proportion of healthcare costs paid directly by households declined significantly over the...

16 Nov 2026

Read →

Most Read

01

Truck Crash and Fire Kill 14, Injure 30 in UAE’s Fujairah

International

02

Narendra Modi’s 25-Year Political Journey: Rise, Reform, Controversy and the Making of a New Political Era

03

₹220 Crore to Become a Dog? The Viral Japanese Story Has a Very Different Reality

International

04

Filmmaker Sanjay Gupta Passes Away in Mumbai; Director of Kaante and Shootout at Wadala Dies After Fall

National

05

Trisha Krishnan Attends Independence Day Celebrations as CM Vijay Hoists National Flag in Chennai

Politics

Loading trending stories...

Advertisement

NationPath

Astro Intelligence

Discover personalised insights, timing patterns and intelligence reports powered by NationPath Astro Engine.

✦ Kundli Intelligence✦ Daily Insights✦ Premium Reports
Explore Astro